Tech Company Financing Transactions

Claryx Funding Round

Claryx, based in Long Island City, secured $3.5 million from Outlander VC, 640 Oxford Ventures and Boost VC.

Transaction Overview

Company Name
Announced On
8/4/2026
Transaction Type
Venture Equity
Amount
$3,500,000
Round
Seed
Proceeds Purpose
The company intends to use the funds to expand operations and its R&D efforts.

Company Information

Company Status
Private & Independent
Industry
Life Sciences
Mailing Address
45-18 Court Square West, 6th Floor
Long Island City, NY 11101
USA
Phone
Undisclosed
Email Address
Overview
Our Mission: To build an immune system for the places we share; On any given day, roughly 1 in 38 U.S. hospital patients carries an infection they didn't arrive with, a problem that costs as much as $45 billion a year and is associated with more deaths than breast cancer or car accidents.
Profile
Claryx LinkedIn Company Profile
Social Media
Claryx Company Twitter Account
Company News
Claryx News
Facebook
Claryx on Facebook
YouTube
Claryx on YouTube

Management Team

Title
Name
Email & Social
Chief Executive Officer
Kurt Hackenberger
  Kurt Hackenberger LinkedIn Profile  Kurt Hackenberger Twitter Account  Kurt Hackenberger News  Kurt Hackenberger on Facebook
Chief Scientific Officer
Dirk Hackenberger
  Dirk Hackenberger LinkedIn Profile  Dirk Hackenberger Twitter Account  Dirk Hackenberger News  Dirk Hackenberger on Facebook


 

 

Browse more venture capital transactions:

Prev: 8/4/2026: QuantHealth venture capital transaction
Next: 8/4/2026: Delightree venture capital transaction

 

Share this article

 


About Our Venture Capital Transactions Database

We record every notable VC transaction. VC investment data records reported here are sourced from publicly available VC deal announcements. The data comes to us via our partnership with VentureDeal.com, an affiliated venture.

 


Additional Resources for Entrepreneurs

Lists of Venture Capital and Private Equity Firms

Franchise Opportunities

Contributors

Business Glossary